| Typicality: | 0.398 |
| Saliency: | 0.406 |
| often | 5 | temporal |
| despite these promising results | 4 | other |
| for cancer | 4 | other |
| drug → fail in → clinical trials | 32 |
| drug → fail in → human trials | 12 |
| drug → failed in → clinical trials | 10 |
| drug → fail in → human clinical trials | 3 |
| drug → failed in → human clinical trials | 3 |
| drug → fail in → late-stage clinical trials | 3 |
| negative | neutral | positive |
| 0.733 | 0.239 | 0.028 |
| Raw frequency | 63 |
| Normalized frequency | 0.406 |
| Modifier score | 0.692 |
| Perplexity | 36.061 |